160 related articles for article (PubMed ID: 1942943)
1. [Successful lysis of a septic thrombosis of the superior vena cava using recombinant tissue-plasminogen activator].
Schranz D; Haugwitz D; Zimmer B; Schumacher R
Klin Padiatr; 1991; 203(5):363-5. PubMed ID: 1942943
[TBL] [Abstract][Full Text] [Related]
2. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
Collen D; Stassen JM; De Cock F
Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
[TBL] [Abstract][Full Text] [Related]
4. [Thrombolysis with rt-PA in children with arterial and venous thromboses--a new therapy concept].
Nowak-Göttl U; Kreuz WD; Schwabe D; Linde R; Kornhuber B
Klin Padiatr; 1991; 203(5):359-62. PubMed ID: 1942942
[TBL] [Abstract][Full Text] [Related]
5. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
[TBL] [Abstract][Full Text] [Related]
6. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
7. Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activator.
Knöfler R; Dinger J; Kabus M; Müller D; Lauterbach I; Rupprecht E; Taut-Sack H; Weissbach G
Semin Thromb Hemost; 2001; 27(2):169-74. PubMed ID: 11372772
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis in newborns and infants.
Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
[TBL] [Abstract][Full Text] [Related]
9. [Thrombolytic therapy of deep venous thrombosis with rt-PA].
Zimmermann R; Horn A; Harenberg J; Diehm C; Müller-Bühl U; Kübler W
Klin Wochenschr; 1988; 66 Suppl 12():137-42. PubMed ID: 3126342
[TBL] [Abstract][Full Text] [Related]
10. [Use of recombinant tissue plasminogen activator (rt-PA) in occluding thrombosis of a Hickman catheter after bone marrow transplantation: clinical and coagulation physiologic aspects].
Eckhof-Donovan S; Michelmann I; Nürnberger W; Stieh J; Rost B; Kemperdick H; Göbel U
Klin Padiatr; 1993; 205(6):435-9. PubMed ID: 8309209
[TBL] [Abstract][Full Text] [Related]
11. [Thromboses of the subclavian vein and jugular vein and superior vena cava: sonographic diagnosis and control of treatment using tissue-type plasminogen activator therapy].
Bloching H; Reuss JA; Seitz K; Rettenmaier G
Ultraschall Med; 1989 Dec; 10(6):314-7. PubMed ID: 2516362
[TBL] [Abstract][Full Text] [Related]
12. Use of tissue type plasminogen activator in neonates: case reports and review of the literature.
Smets K; Vanhaesebrouck P; Voet D; Schelstraete P; Govaert P
Am J Perinatol; 1996 May; 13(4):217-22. PubMed ID: 8724722
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic therapy of deep vein thrombosis with continuous intravenous infusion of a recombinant tissue plasminogen activator.
Zimmerman R; Gürsoy A; Horn A; Harenberg J; Diehm C; Kübler W
Semin Thromb Hemost; 1991 Jan; 17(1):48-54. PubMed ID: 1904629
[TBL] [Abstract][Full Text] [Related]
15. [rt-PA in extracardiac thromboembolic vascular occlusions].
Cortellaro M; Cofrancesco E; Polli EE
Ann Ital Med Int; 1990; 5(1):61-9. PubMed ID: 2119673
[TBL] [Abstract][Full Text] [Related]
16. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
[TBL] [Abstract][Full Text] [Related]
17. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).
Trusen B; Ries M; Zenker M; Rauh M; Beinder E; Keuper H; Harms D
Semin Thromb Hemost; 1998; 24(6):599-604. PubMed ID: 10066156
[TBL] [Abstract][Full Text] [Related]
18. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
[TBL] [Abstract][Full Text] [Related]
20. [Local thrombolysis in peripheral arterial occlusion].
Hess H
Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
